Waters forecasts first-quarter profit below Wall Street estimates, shares slide
Feb 9 (Reuters) - Waters said on Monday it expects first-quarter profit to fall below Wall Street estimates, sending shares of the lab equipment maker down nearly 12% in premarket trading as investors weighed the outlook and a revenue decline at the Becton Dickinson unit it acquired last year.
The company, however, forecast better-than-expected full-year profit, reflecting contributions from its $17.5 billion buyout of Becton Dickinson's bioscience and diagnostics business, which it bought to broaden its reach in clinical and diagnostic applications.
Separately, Becton posted an 8.3% year-over-year decline in revenue from its life sciences segment, which includes biosciences and diagnostic solutions, for the quarter ended December 31. The business posted sales of $766 million.
"Overall, it looks like the BD revenue came in lighter than expected, so it may be a heavier lift to improve operations in that business... than previously expected," Morningstar analyst Julie Utterback said.
Waters forecast first-quarter profit of $2.25 to $2.35 per share, versus analysts' average estimate of $2.51, according to LSEG data.
For 2026, Waters said it expects 5.3% combined company sales growth at the midpoint, including the benefit from the acquisition.
It projected 2026 adjusted profit of $14.30 to $14.50 per share, above analysts' average estimate of $14.32.
Waters expects full-year organic revenue of $3.35 billion to $3.40 billion, compared with estimates of $3.36 billion, and said the acquired Becton Dickinson business should add about $3 billion to reported 2026 revenue.
The unit brought in sales of $766 million in the quarter, below analysts' estimate of $1.3 billion.
Waters supplies lab equipment and technology globally, with most revenue coming from biopharma customers that use its tools for research and drug development.
The company reported fourth-quarter adjusted profit of $4.53 per share, topping estimates of $4.51, while revenue rose about 7% to $932 million, compared with expectations of $928.1 million.
(Reporting by Gnaneshwar Rajan in Bengaluru; Editing by Tasim Zahid)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
If You Missed XRP, Don’t Miss the Best Crypto Presale in DOGEBALL

Gold price to accelerate and hit new record highs after this event – technical analyst
Gold price to accelerate and hit new record highs after this event – technical analyst
Top Crypto Gainers today 3 March: Why are NEAR, Virtuals, and Morpho surging?
